Last reviewed · How we verify
Zepbound — clinical trials
Key trials
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese · PHASE2
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder · PHASE2
- Tirzepatide to Slow Biological Aging · PHASE2
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial · PHASE2, PHASE3
- Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors · PHASE1
- Tirzepatide Weight Loss for MRD+ Early Breast Cancer · PHASE2
- GLP-1 Medicines and Mental Health Changes · NA
- Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese · PHASE2
- Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer · PHASE2
- Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults · PHASE2
- TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation · PHASE2
- GLP-1s to Enhance Lasting Optimal Weight · PHASE4
See also
- Full profile: Zepbound
- Side effects: /side-effects
- Dosage & administration: /dosage
- Mechanism of action: /mechanism
- Cost & pricing: /cost
- Drug interactions: /interactions
- Patents & exclusivity: /patents
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing